Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» With $2.5B in Herceptin sales on the line, Roche sues Pfizer for biosim patent infringement
With $2.5B in Herceptin sales on the line, Roche sues Pfizer for biosim patent infringement
With $2.5B in Herceptin sales on the line, Roche sues Pfizer for biosim patent infringement
Submitted by
admin
on November 21, 2017 - 12:14pm
Source:
Fierce Pharma
News Tags:
Herceptin
Roche
Pfizer
biosimilars
breast cancer
Headline:
With $2.5B in Herceptin sales on the line, Roche sues Pfizer for biosim patent infringement
Do Not Allow Advertisers to Use My Personal information
